Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Caspase-activated DNase (CAD) is crucial for DNA fragmentation during apoptosis.
• The CAD gene is located on chromosome 1p36, a region frequently deleted in human cancers like hepatocellular carcinoma (HCC).
• This suggests a potential tumor-suppressive role for CAD in hepatocarcinogenesis.

Purpose of the Study:

• To investigate the role of CAD gene mutations and alternative splicing in human HCC.
• To analyze CAD transcripts and mutations in HCC cell lines and normal tissues.

Main Methods:

• Analysis of CAD gene transcripts in six human HCC cell lines, normal liver tissue, and peripheral blood leukocytes.
• Identification of alternatively spliced CAD transcripts and genomic mutations.
• Assessment of DNA fragmentation efficiency following UV-induced apoptosis.

Main Results:

• Alternatively spliced CAD transcripts were found in both HCC and normal samples.
• Abundant alternatively spliced CAD transcripts preserving ICAD interaction domains were detected in poorly differentiated HCC cells (Mahlavu, SK-Hep1).
• An abnormal transcript with an Alu repeat insertion and missense mutations in CAD were identified in HCC cell lines, correlating with reduced DNA fragmentation efficiency.

Conclusions:

• Frequent mutations and aberrant splicing of the CAD gene occur in human HCC cells.
• These alterations, especially in poorly differentiated HCC, suggest a significant role for CAD in hepatocarcinogenesis.
• CAD may function as a tumor suppressor in the development of liver cancer.